Clinical Trial Update: Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety of intramuscular allogeneic PLX-PAD cells for treating Critical Limb Ischemia; the report focuses on safety outcomes in Perip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• PLX PAD

Snippet

Sponsor: Pluristem Ltd. | Conditions: Peripheral Artery Disease, Peripheral Vascular Disease | Phase 1 | Status: COMPLETED